have shown that the activation of the EGFR pathway can upregulate the expression of PD-L1 and other immunosuppressive factors including cytokine production and accumulation of tumor-associated macrophages, suggesting that EGFR on NSCLC cell membrane could remodel the tumor microenvironment (70). This evidence concerns the gene EGFR and non-small cell lung carcinoma.